Patrick Amstutz, Ph.D., has been CEO of Molecular Partners since November 2016. He co-founded Molecular Partners and has been a member of the company’s management team since its inception in 2004, also holding the positions of CBO and COO. In those roles, Dr. Amstutz was responsible for business development, alliance management, and research and development operations. He has established a wide range of commercial collaborations and licensed several key technologies. Since 2017, Dr. Amstutz has been vice president of the board of the Swiss Biotech Association. Dr. Amstutz holds a Master of Science from the ETH Zurich and a Ph.D. in molecular biology from the University of Zurich. As CEO, Dr. Amstutz is not member of any committees of the board of directors of the company.